Lyndra Therapeutics
Biotechnology ResearchMassachusetts, United States11-50 Employees
As of March 26, 2025, Lyndra Therapeutics has ceased operations. Please direct any inquiries by email to Craig Jalbert at cjalbert@vlpc.com.
Insights
Recent Acquisition Sun Pharmaceutical Industries acquired a 16.7% stake in Lyndra Therapeutics for $30 million, indicating strong industry interest and potential partnership opportunities in advanced drug delivery technologies.
Funding & Growth Lyndra Therapeutics secured $101 million in Series E funding, highlighting significant investor confidence and financial backing that could support expansion into new therapeutic areas or technology development.
Strategic Collaborations Partnerships with the National Institutes of Health on long-acting treatment alternatives for opioid use disorder suggest opportunities for collaboration in government-funded research and innovative healthcare solutions.
Leadership Changes Recent leadership changes, including hiring a new CEO and strategic workforce adjustments, create openings for consulting, leadership development, and management consulting services to support transformation initiatives.
Technological Focus Lyndra’s focus on cutting-edge delivery technology for long-acting oral therapies presents opportunities for companies specializing in biotech manufacturing, formulation development, and advanced drug delivery systems to collaborate or provide services.
Similar companies to Lyndra Therapeutics
Lyndra Therapeutics Tech Stack
Lyndra Therapeutics uses 8 technology products and services including Open Graph, Underscore.js, SweetAlert, and more. Explore Lyndra Therapeutics's tech stack below.
- Open GraphContent Management System
- Underscore.jsJavascript Libraries
- SweetAlertJavascript Libraries
- jQuery MigrateJavascript Libraries
- SwiperJavascript Libraries
- YouTubeVideo Players
- Adobe Creative SuiteVisualisation Software
- IoniconsWeb Fonts
Media & News
Lyndra Therapeutics's Email Address Formats
Lyndra Therapeutics uses at least 1 format(s):
| Lyndra Therapeutics Email Formats | Percentage |
| FLast@lyndra.com | 50% |
| FLast@lyndra.com | 50% |
Frequently Asked Questions
Where is Lyndra Therapeutics's headquarters located?
Lyndra Therapeutics's main headquarters is located at 65 Grove Street Suite 301 Watertown, Massachusetts 02472 United States. The company has employees across 2 continents, including North AmericaAsia. What is Lyndra Therapeutics's phone number?
You can contact Lyndra Therapeutics's main corporate office by phone at +1-817-415-****
What is Lyndra Therapeutics's official website and social media links?
Lyndra Therapeutics's official website is lyndra.com and has social profiles on LinkedInCrunchbase.What is Lyndra Therapeutics's SIC code NAICS code?
Lyndra Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Lyndra Therapeutics have currently?
As of March 2026, Lyndra Therapeutics has approximately 25 employees across 2 continents, including North AmericaAsia. Key team members include Vp Of Financial Planning & Analysis: T. B.Vice President Clinical Development: P. B.Vice President Regulatory Affairs: M. C.. Explore Lyndra Therapeutics's employee directory with LeadIQ.What industry does Lyndra Therapeutics belong to?
Lyndra Therapeutics operates in the Biotechnology Research industry. What technology does Lyndra Therapeutics use?
Lyndra Therapeutics's tech stack includes Open GraphUnderscore.jsSweetAlertjQuery MigrateSwiperYouTubeAdobe Creative SuiteIonicons. What is Lyndra Therapeutics's email format?
Lyndra Therapeutics's email format typically follows the pattern of FLast@lyndra.com. Find more Lyndra Therapeutics email formats with LeadIQ. How much funding has Lyndra Therapeutics raised to date?
As of March 2026, Lyndra Therapeutics has raised $101M in funding. The last funding round occurred on Dec 21, 2023 for $101M.When was Lyndra Therapeutics founded?
Lyndra Therapeutics was founded in 2015.
Company Overview
- Headquarters
- 65 Grove Street Suite 301 Watertown, Massachusetts 02472 United States
- Phone number
- +1-817-415-****
- Website
- lyndra.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2015
- Employees
- 11-50
Media & News
Funding & Financials
- $101M
Lyndra Therapeutics has raised a total of $101M of funding over 7 rounds. Their latest funding round was raised on Dec 21, 2023 in the amount of $101M.
- $10M$25M
Lyndra Therapeutics's revenue is estimated to be in the range of $10M$25M
Funding & Financials
- $101M
Lyndra Therapeutics has raised a total of $101M of funding over 7 rounds. Their latest funding round was raised on Dec 21, 2023 in the amount of $101M.
- $10M$25M
Lyndra Therapeutics's revenue is estimated to be in the range of $10M$25M
Company Leadership
T. B.Vp Of Financial Planning & Analysis
P. B.Vice President Clinical Development- M. C.Vice President Regulatory Affairs
- A. J.President And Chief Executive Officer
- J. U.Vice President, Clinical Development
Employee Directory
- T. S.Director
C. Y. Z.Associate Director- M. O.Associate Director, Analytical Research And Development
- D. V.Controller
- O. A.Senior Director
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
